Stock comparison
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HRMY
Harmony Biosciences Holdings
Market cap
$1.75B
Sector
Healthcare
INCY
Incyte
Market cap
$19.46B
Sector
Healthcare
Overall winner
Harmony Biosciences Holdings HRMY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
| Strategy | HRMY | INCY | Winner |
|---|---|---|---|
| Warren Buffett | 67B | 63C | HRMY |
| Benjamin Graham | 60C | 73B | INCY |
| Philip Fisher | 75B | 61C | HRMY |
| Peter Lynch | 62C | 50C | HRMY |
| Joel Greenblatt | 28F | 45D | INCY |
| Charlie Munger | 62C | 60C | HRMY |
| Terry Smith | 67B | 66B | HRMY |
| Metric | HRMY | INCY |
|---|---|---|
| Market cap | $1.75B | $19.46B |
| P/E (TTM) | 11.8x | 14.0x |
| EV/EBIT | 6.4x | 12.4x |
| ROIC (TTM) | 12.5% | 19.98% |
| Gross margin | 76.55% | 91.86% |
| Net margin | 16.2% | 26.71% |
| Revenue CAGR 5y | 29.85% | 14.55% |
| EPS CAGR 5y | 46.45% | 11.26% |
| Debt / Equity | 0.2x | 0.0x |
| Dividend yield | 0.0% | 0.0% |
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
INCY leads on
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.